Corcept Therapeutics (CORT) Net Margin (2012 - 2026)
Corcept Therapeutics (CORT) posted Net Margin of 16.45% for Q2 2026, down 1.35 percentage points from 17.80% a year earlier but up 35.37 percentage points from the prior quarter.
Corcept Therapeutics (CORT) Net Margin (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Margin at Corcept Therapeutics was 6.52%, down 11.91 percentage points year-over-year; for FY2025, it came in at 12.89%, down 7.81 percentage points from FY2024.
- Annual Net Margin has declined for four consecutive years, with a five-year change of -17.06 percentage points (FY2020 to FY2025).
- In prior years, Corcept Therapeutics' Net Margin was 20.70% in FY2024 (-1.17 pp), 21.87% in FY2023 (-3.33 pp), 25.20% in FY2022 (-5.54 pp) and 30.74% in FY2021 (+0.79 pp).
- Quarterly Net Margin has run from a low of -18.92% in Q1 2026 to a high of 33.96% in Q3 2022 over five years.
- On a year-over-year basis, Net Margin has declined in each of the last seven quarters, with an average year-over-year change of -8.72 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Net Margin in the past five years was Q4 2023, with a gain of 6.96 percentage points; the weakest was Q1 2026, with a drop of 31.83 percentage points.
- According to Business Quant data, Net Margin for the three prior quarters was -18.92% (Q1 2026), 11.83% (Q4 2025) and 9.32% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Corcept Therapeutics | 12.50 Bn | 11.06 Bn | 252.09 Mn | 16.45% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.45% |
| Mar 31, 2026 | -18.92% |
| Dec 31, 2025 | 11.83% |
| Sep 30, 2025 | 9.32% |
| Jun 30, 2025 | 17.80% |
| Mar 31, 2025 | 12.90% |
| Dec 31, 2024 | 16.71% |
| Sep 30, 2024 | 25.58% |
| Jun 30, 2024 | 21.44% |
| Mar 31, 2024 | 18.74% |
| Dec 31, 2023 | 23.00% |
| Sep 30, 2023 | 25.22% |
| Jun 30, 2023 | 23.24% |
| Mar 31, 2023 | 14.96% |
| Dec 31, 2022 | 16.04% |
| Sep 30, 2022 | 33.96% |
| Jun 30, 2022 | 26.50% |
| Mar 31, 2022 | 24.33% |
| Dec 31, 2021 | 32.44% |
| Sep 30, 2021 | 31.70% |
Corcept Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CORT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();